Breast Implants Market Size To Attain USD 5.38 Bn By 2033

Published Date : 12 Feb 2024

The global breast implants market size surpassed USD 2.6 billion in 2023 and is projected to attain around USD 5.38 billion by 2033, growing at a CAGR of 7.60% from 2024 to 2033.

Breast Implants Market Size and Growth Rate From 2024 to 2033

Market Overview

Breast implants are silicone shells filled with either saline or silicone gel, and they are widely used by woman to enhance the size and shape of their natural breasts. However, silicone-based breast implants give a more natural feel than saline breast implants. Silicone breast implants are FDA-approved for augmentation in women aged 22 or above, whereas saline breast implants are FDA-approved for augmentation in women aged 18 or above.

The rapidly growing demand for cosmetic surgeries is projected to boost the growth of the breast implants market during the forecast period. Breast implantation surgery has increased immensely with the growing demand for cosmetic surgeries. Breast implants are medical devices (prostheses) that are surgically inserted into the person's breasts. Women with a preference for larger breast sizes enhancing their aesthetic appeal to boost their self-esteem and body image are likely to complement the breast implant market growth. Rising initiatives by public and private organizations toward breast implants have led to an increasing number of cosmetic surgeries.

The growth of the global breast implants market is driven by several other factors, including growth in healthcare infrastructure, increasing number of breast implant surgeries, growing awareness of cosmetic surgeries, technological advancements in the existing products of breast implants for breast augmentation and reconstruction, and increasing investment in advanced breast implants. Additionally, the surge in breast cancer cases has propelled the demand for reconstructive surgeries during the forecast period.

Regional Snapshot

North America is expected to hold the largest market share during the forecast period. The growth of the region is attributed to the presence of well-established healthcare infrastructure, increasing investment in medical devices, increasing number of breast augmentation surgeries, rapid growth of the healthcare sector, technological advancement in medical devices, rising awareness of breast implant campaigns, and the increasing prevalence of breast cancer.

  • According to the data provided by the American Cancer Society, Breast cancer accounts for 12.5% of all new annual cancer cases worldwide, and nearly 30% of all newly diagnosed cancers in women are breast cancer each year. Thus, the increasing prevalence of breast cancer has propelled the breast implants market's expansion in the coming years.

The United States breast implants market has a significant CAGR in the region owing to the rise in disposable income, rise in medical tourism, increase in product approvals by the FDA, presence of prominent companies, high demand for cosmetic surgeries, rising research and development expenditure, and increasing women's inclination toward breast augmentation and reconstruction surgeries. Moreover, Prominent market players are aggressively working toward more efficient solutions such as product launches, collaborations, and mergers and acquisitions. Thus, this is expected to propel the market growth in the region during the forecast period.

Breast cancer is one of the most common cancers in women in the U.S. It accounts for nearly 30% or 1 in 3 new female cancers every year. The American Cancer Society's estimated breast cancer cases in the U.S. for 2024 are nearly 310,720 new cases of invasive breast cancer that will be diagnosed in women, which results in an increasing number of breast implant surgeries.

Breast Implants Market Report Scope

Report Coverage Details
Market Revenue in 2023 USD 2.6 Billion
Projected Forecast Revenue by 2033 USD 5.38 Billion
Growth Rate from 2024 to 2033 CAGR of 7.60%
Largest Market North America
Base Year 2033
Forecast Period 2024 to 2033
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics


Increasing number of breast augmentation surgeries

The rapidly rising number of breast augmentation surgeries is projected to fuel the market’s expansion in the coming years. Breast augmentation is widely performed and common type of cosmetic plastic surgery procedure globally. Breast augmentation is a cosmetic surgery that uses breast implants or fat transfer to enhance the size of the breasts to give natural feel and which makes the women more confident.

  • In 2022, American Board of Plastic Surgery (ABPS) Member Surgeons performed nearly 300,000 breast augmentation procedures, according to ASPS statistics. To assess practice patterns and surgical techniques over time, Dr. Stein and colleagues analyzed data from the Continuous Certification process of the ABPS. Therefore, the increasing number of breast augmentation surgeries is expected to drive market growth during the forecast period.


Side effects of breast implant surgeries

The adverse side effects and post-surgery complications associated with breast implantation surgeries are projected to hamper the growth of the global breast implants market. Breast implantation surgeries can have numerous post-surgery complications. Patients who opt for breast implantation are at a higher risk of developing cancer, which mostly grows in the scar tissue or fluid surrounding the implant. Moreover, the lack of awareness of breast implants in middle- and lower-income countries is likely to limit the expansion of the global breast implants market during the forecast period.

  • As of June 30, 2023, the U.S. FDA has received a total of 1264 U.S. and global medical device reports (MDRs) of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).


Increasing investment in the healthcare infrastructure and research and development activities

The rapidly increasing investment in the healthcare infrastructure, along with ongoing research and development activities, are expected to offer a lucrative opportunity for market growth during the forecast period. The breast implants market is witnessing well-established healthcare infrastructure due to an increase in healthcare investment. Therefore, sophisticated healthcare facilities offer effective treatment options for breast augmentation and reconstructive surgeries, which is expected to contribute to the market's growth during the forecast period.

Recent Developments

  • In January 2022, Mentor Worldwide LLC announced the U.S. Food and Drug Administration (FDA) approval of its MENTOR MemoryGel BOOST breast implant for breast augmentation in women aged 22 years and above.
  • In June 2022. Coll Plant announced the initiation of a study in large animals for its 3D bio-printed regenerative breast implant program, addressing the demands of breast reconstruction.

Key Market Players

  • Sientra, Inc.
  • Shanghai Kangning Medical Supplies Ltd.
  • Sebbin
  • Polytech Health and Aesthetics GmBH
  • Mentor Worldwide LLC
  • Laboratoires Arion
  • HansBioMed
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • GC Aesthetics
  • Establishment Labs S.A.
  • Allergan plc
  • AbbVie Inc.

Market Segmentation

By Product

  • Silicone Breast Implants
  • Saline Breast Implants

By Application

  • Reconstructive Surgery
  • Cosmetic Surgery

By End-User

  • Hospitals
  • Cosmetology Clinics
  • Others

Buy this Research Report@

You can place an order or ask any questions, please feel free to contact at | +1 650 460 3308